Corticosteroids and peptic ulcer: meta‐analysis of adverse events during steroid therapy

Journal of Internal Medicine

Volumn 236, Issue 6, 1994, Pages 619-632

  CONN, H O ^a   POYNARD, T ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CORTISONE; DEXAMETHASONE; HYDROCORTISONE; METHYLPREDNISOLONE; PARAMETHASONE; PREDNISOLONE; PREDNISONE; TRIAMCINOLONE;

ARTICLE; CLINICAL TRIAL; CUSHING SYNDROME; HUMAN; HYPERTENSION; META ANALYSIS; OSTEOPOROSIS; PEPTIC ULCER; PRIORITY JOURNAL; PSYCHOSIS;

ADRENAL CORTEX HORMONES; CONFOUNDING FACTORS (EPIDEMIOLOGY); DOUBLE-BLIND METHOD; HUMAN; PEPTIC ULCER; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES;

EID: 0028561942     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.1994.tb00855.x     Document Type: Article

References (137)

1. Acute perforation of duodenal ulcer during ACTH and cortisone therapy
2. Activation of peptic ulcer during pituitary adrenocorticotropic hormone therapy: report of three cases
3. Major undesirable side‐effects resulting from prednisolone and prednisone
4. Peptic ulcers in rheumatoid patients receiving corticosteroid therapy
5. Peptic ulcer during treatment of rheumatoid arthritis with cortisone derivatives
6. The incidence of peptic ulcer among patients on long term prednisone therapy
7. Long‐term treatment with corticosteroids in rheumatoid arthritis
8. The effects of cortisone and adrenocorticotrophic hormone on poliomyelitis and on other virus infections
9. Tuberculosis occurring in association with corticosteroid treatment
10. Corticosteroids and pulmonary tuberculosis. Activation of four cases
11. Drug‐induced disorders of carbohydrate and fat metabolism
12. Steroid diabetes, diabetes mellitus appearing during treatment with pituitary‐adrenal hormones
13. Acute pancreatic lesions in patients treated with ACTH and adrenal corticoids
14. Mental disturbances associated with ACTH and cortisone: a review of explanatory hypotheses
15. Drug‐induced endocrine dysfunction
16. Nonassociation of adrenocorticosteroid therapy and peptic ulcer
17. Association of adrenocorticosteroid therapy and peptic ulcer disease
18. Adrenocorticosteroid administration and peptic ulcer: a critical analysis
19. The retrieval of randomized clinical trials in liver disease from the medical literature. A comparison of MEDLARS and manual methods
20. Inadequacy of the literature in the relationship between drugs, ulcers, and gastrointestinal bleeding
21. Beta blockade during and after myocardial infarction: an overview of the randomized trials
22. Meta‐analysis in clinical trials
23. Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency
24. Plasma corticosteroids in infants with the respiratory distress syndrome
25. Dexamethasone as treatment in cerebrovascular disease. 2 A controlled study in acute cerebral infarction
26. Prednisone treatment for stable pulmonary emphysema
27. Dexamethasone in the treatment of acute bacterial meningitis: the effect of study design on the interpretation of results
28. A double‐blind study of the effectiveness of Cortisol in the management of severe infections
29. Adrenocorticosteroid therapy in alcoholic hepatitis: a prospective double‐blind randomized study
30. The effect of low doses of prednisolone compared with placebo on function and on the hypothalamic pituitary adrenal axis in patients with rheumatoid arthritis
31. Dexamethasone and severe head injury. A prospective double‐blind study
32. A controlled study of short‐term prednisone treatment in adults with membranous nephropathy
33. The effectiveness of hydrocortisone in the management of severe infections. A double‐blind study
34. Negative results of prednisone therapy in viral hepatitis
35. Double‐blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy
36. The effects of early corticosteroid therapy on the skin eruption and pain of Herpes zoster
37. Corticosteroids and croup. Controlled double‐blind study
38. A controlled trial of prednisone, in low dosage, in patients with chronic airways obstruction
39. Treatment of acute non‐tuberculous salpingitis with antibiotics alone and in combination with gluco‐corticoids. A prospective, double‐blind, controlled study of the clinical course and prognosis
40. Double‐blind study on the effects of steroids on severe closed head injury
41. Failure of systemically administered corticosteroids to suppress UVB‐induced delayed erythema
42. Steroid therapy in severe viral hepatitis. A double‐blind, randomized trial of methyl‐prednisolone versus placebo
43. A controlled study of two preparations, para‐methasone, propoxyphene, and aspirin and propoxyphene and aspirin in the treatment of arthritis
44. Chlorambucil vs. combined chlorambucil‐corticosteroid therapy in chronic lymphocytic leukemia
45. Double‐blind crossover trial of depot tetracosactrin in hay fever
46. Effects of using dexamethasone and placebo in the treatment of prolapsed lumbar disc
47. Alcoholic hepatitis. Natural history and evaluation of prednisolone therapy
48. Immediate treatment of apoplexy (Correspondence)
49. Corticosteroids and fluorouracil toxicity
50. Alternate‐day prednisone: preliminary report of a double‐blind controlled study
51. A controlled trial of prednisone treatment of sarcoidosis
52. Dexamethasone in croup. A controlled study
53. Treatment of sarcoidosis. Report of a controlled therapeutic trial
54. Corticosteroids in pulmonary tuberculosis
55. Double‐blind studies on the use of steroids in the treatment of acute hemarthrosis in patients with hemophilia
56. Effectiveness of betamethasone in management of severe infections
57. The effects of short‐term corticosteroid therapy on the symptoms of infectious mononucleosis pharyngotonsillitis: a double‐blind study
58. A prospective randomized study to determine the efficacy of steroids in treatment of croup
59. Prednisone as maintenance treatment for ulcerative colitis in remission
60. A double blind controlled trial of prednisolone‐21‐phosphate suppositories in the treatment of idopathic proctitis
61. Adrenocosteroid therapy of alcoholic hepatitis
62. Effects of methylprednisolone on the ischemic damage in patients with acute myocardial infarction
63. Adreno‐corticosteroid treatment of hydrocarbon pneumonia in children—a cooperative study
64. Comparison of the effect of prednisone and a placebo in the treatment of multiple myeloma
65. Evaluation de la methylpred‐nisolone dans le traitement des laryngites aigues de l'enfant
66. Local treatment of ulcerative colitis with prednisolone‐21‐phosphate enemata
67. The use of steroids in Bell's palsy: a prospective controlled study
68. A controlled study of the effects of single doses of hydrocortisone on the resolution of acute attacks of asthma
69. Betamethasone in stroke (Correspondence)
70. Steroid response in stable chronic obstructive pulmonary disease
71. Corticosteroid therapy of preterminal gastrointestinal cancer
72. A controlled trial of the effect of steroids in obstructive airway disease
73. Injection of corticosteroids into mother to prevent neonatal respiratory distress syndrome
74. Effect of methylprednisolone on myocardial preservation during coronary artery surgery
75. Dexamethasone in acute stroke
76. ACTH‐treatment of acute viral hepatitis
77. The value of dexamethasone in the postoperative treatment of lumbar disc prolapse
78. Prednisone as an adjunct in the chemotherapy of lymph node‐bronchial tuberculosis in childhood: a double‐blind study
79. Steroid therapy in acute cerebral infarction
80. Effects of a single large intravenous dose of methylprednisolone sodium succinate
81. The tolerance and safety of intravenously administered benzyl alcohol in methylprednisolone sodium succinate formulations in normal human subjects
82. Dexamethasone in tuberculous meningitis
83. Double‐blind study of the effects of dexamethasone on acute stroke
84. Effect of therapy with methylprednisolone on the size of myocardial infarcts in man
85. Prolapsed lumbar disc treated with intramuscularly administered dexamethasonephosphate. A prospectively planned, double‐blind, controlled clinical trial in 52 patients
86. Corticosteroid therapy in severe alcoholic hepatitis. A double‐blind drug trial
87. A controlled trial of alternate day prednisolone as a maintenance treatment for ulcerative colitis in remission
88. A double‐blind study of eighty‐two cases of infectious mononucleosis treated with corticosteroids
89. A comparison of coagulation factor replacement with and without prednisolone in the treatment of haematuria in haemophilia and Christmas disease
90. Tourtellotte WW. Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo—final report
91. Steroids in the treatment of clinical septic shock
92. Use of a short course of prednisone for treating middle ear effusion. A double‐blind crossover study
93. Re‐evaluation of short‐term steroid therapy for perifocal brain edema
94. Response to corticosteroids in chronic bronchitis
95. A controlled trial of 6‐methylprednisolone in acute alcoholic hepatitis
96. Sturd‐evant RAL. National Cooperative Crohn's Disease Study: adverse reactions to study drugs
97. Low dose steroids and clinical relapse in Crohn's disease: a controlled trial
98. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis
99. Ewvaluation of corticosteroid treatment in aspiration of gastric contents: a controlled clinical trial
100. Cortisone treatment of Bell's palsy
101. Prednisolone in the treatment of pulmonary tuberculosis
102. A controlled trial of prednisolone in the treatment of infective hepatitis
103. A controlled trial of steroid therapy in massive hepatic necrosis
104. A prospective trial of steroid therapy in severe viral hepatitis
105. Treatment of ulcerative colitis with topical hydrocortisone hemisuccinate sodium; controlled trial employing restricted sequential analysis
106. A double‐blind placebo‐controlled trial of methylprednisolone pulse therapy in active rheumatoid disease
107. The efficacy of steroids in the treatment of idiopathic sudden hearing loss
108. Pericardial pain in acute myocardial infarction. Double blind trial of steroid therapy
109. Intramuscular ACTH or placebo in the treatment of hyperemesis gravidarum
110. Endocrinology
111. Corticosteroid complications in respiratory disease
112. Pathogenetic mechanism of steroid acne
113. Complications of corticosteroid therapy
114. Oral glucocorticoids and their complications
115. Guidelines for the use of systemic glucocorticosteroids in the management of selected infections
116. Glucocorticosteroids I: anti‐inflammatory mechanisms
117. Cushing's Syndrome
118. Effects of glucocorticoids on carbohydrate metabolism
119. Glucocorticoid‐induced osteoporosis: pathogenesis and management
120. Corticosteroid‐induced osteoporosis
121. Mechanisms of glucocorticoid‐induced hypertension
122. Effects of corticosteroids on bone and blood pressure
123. Hydrocortisone‐induced hypertension in humans: pressor responsiveness and sympathetic function
124. Psychologic side effects of therapy with corticosteroids
125. Steroid‐induced psychiatric syndromes. A report of 14 cases and a review of the literature
126. Doran A. Rubinow D, Pickar D. Cognitive effects of corticosteroids
127. Acute adverse reactions to prednisone in relation to dosage
128. Corticosteroids: a review with emphasis on complications of prolonged systemic therapy
129. Tuberculosis after corticosteroid therapy
130. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis
131. Clinical, biochemical and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis
132. Report from the European Association for the Study of the Liver. Randomized trial of steroid therapy in acute liver failure